论文部分内容阅读
目的观察红霉素及其系列制剂和卡介苗素序贯治疗小儿肺炎支原体肺炎的疗效。方法采用开放式对照研究 ,将 112例肺炎支原体肺炎患儿分成 3组 :序贯治疗组为 A组 ,对照组为 B组及 C组 ,比较 3组的治愈率及总有效率。结果序贯治疗 A组与对照 B组治愈率 ,总有效率差异无显著差异 (P>0 .0 5 ) ;C组与 A组、B组治愈率、总有效率差异有显著性意义 (P<0 .0 5 )。结论红霉素及其系列制剂和卡介苗素序贯治疗小儿肺炎支原体肺炎疗效显著 ,复发率低 ,有明显的成本效益优势
Objective To observe the efficacy of erythromycin and its series preparations and BCG sequential treatment of children with Mycoplasma pneumoniae pneumonia. Methods In an open-label study, 112 children with Mycoplasma pneumoniae pneumonia were divided into three groups: group A was treated with sequential therapy, group B was treated with C as control group, and the total effective rate was compared between the three groups. Results There was no significant difference in the cure rate and total effective rate between sequential treatment group A and control group B (P> 0.05); the cure rate and total effective rate difference between C group and A group and B group were significant (P <0 .0 5). Conclusion Erythromycin and its series preparation and BCG sequential treatment of children with Mycoplasma pneumoniae pneumonia have significant effect, low recurrence rate, obvious cost-effectiveness advantage